Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1055-1062

  Pirog, Edyta C ^a   Kleter, Bernhard ^d   Olgac, Semra ^b   Bobkiewicz, Piotr ^f   Lindeman, Jan ^e   Quint, Wim G V ^d   Richart, Ralph M ^c   Isacson, Christina ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c College of Physicians and Surgeons of Columbia University ^*  (United States)

^d Delft Diagnostic Laboratory   (Netherlands)

^e SLOTERVAART HOSPITAL   (Netherlands)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; MESONEPHROMA; PRIORITY JOURNAL; UTERINE CERVIX; WART VIRUS;

EID: 0033815503     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64619-6     Document Type: Article

References (52)

1. The continuing increase in adenocarcinoma of the uterine cervix: A birth cohort phenomenon
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical cancer (IBSCC) Study Group
3. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study
4. Adenocarcinoma of the uterine cervix in Ireland and Sweden: Human papillomavirus infection and biologic alterations
5. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix
6. Human papillomavirus genotype as a major determinant of the course of cervical cancer
7. Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction
8. Glandular lesions of the uterine cervix: Prognostic implications of human papillomavirus status
9. Molecular characterization of adenocarcinoma of the cervix
10. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix
11. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis
12. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade
13. Human papillomavirus and endocervical adenocarcinoma
14. Epidemiology of cervical cancer by cell type
15. Risk factors for cervical cancer by histology
16. Do squamous cell carcinomas and adenocarcinomas of the cervix have the same risk factors?
17. Risk factors for adenocarcinoma of the cervix: A case-control study
18. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: Results from a population-based case-control study
19. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas
20. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses
21. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus
22. Invasive adenocarcinoma and related tumors of the uterine cervix
23. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
24. Adenocarcinoma of the endocervix - A histochemical study
25. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
26. Physical status and expression of HPV genes in cervical cancers
27. Use of polymerase chain reaction amplification for detection of genital human papillomavirus
28. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
29. The viral origin of cervical cancer in Rabat, Morocco
30. The association of human papillomaviruses with nonendocervical types of cervical adenocarcinoma has carcinogenic implications
31. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix
32. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix
33. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia
34. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction
35. Infrequent occurrence of high risk human papillomavirus and p53 mutation in minimal deviation adenocarcinoma of the cervix
36. A distinct region of chromosome 19p 13.3 associated with the sporadic form of adenoma malignum of the uterine cervix
37. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix
38. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18
39. Papillary serous carcinoma of the uterine cervix: A clinicopathologic study of 17 cases
40. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: A report of the first case
41. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component
42. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR)
43. Adenoid basal carcinoma of the uterine cervix: Detection of integrated human papillomavirus in a rare tumor of putative 'reserve cell' origin
44. Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix
45. In situ hybridization for human papillomavirus DNA in uterine adenosquamous carcinoma with glassy cell features ('glassy cell carcinoma')
46. Molecular abnormalities associated with endocrine tumors of the uterine cervix
47. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
48. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer
49. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18
50. Association of human papillomavirus types 16 and 18 E6 proteins with p53
51. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product